EHC Encompass Health Corp
Services-Hospitals · NYSE · SEC CIK 785161 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY19.1%
TTM EPS YoY21.0%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR22.1%
Margins
Gross margin—
Operating margin—
Net margin10.2%
FCF margin7.2%
EBITDA margin—
Returns
ROE25.5%
ROA8.9%
ROIC (approx.)—
Asset turnover0.88x
Leverage & solvency
Liabilities / assets52.9%
Debt / equity0.97x
Current ratio1.09x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.02x
Accruals ratio-9.1%
Payout ratio11.9%
Capex / revenue13.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.94B | $5.37B |
| SG&A expense | $236.20M | $209.20M |
| Interest expense | $123.20M | $137.40M |
| Pretax income | $953.00M | $749.60M |
| Income tax | $192.90M | $150.20M |
| Net income | $566.20M | $455.70M |
| EPS (basic) | 5.62 | 4.53 |
| EPS (diluted) | 5.54 | 4.46 |
| Dividends declared per share | 0.72 | 0.64 |
| Weighted avg. shares (diluted) | 102.20M | 102.20M |
| Balance sheet | ||
| Cash & equivalents | $72.20M | $85.40M |
| Receivables | $619.20M | $593.00M |
| Current assets | $905.90M | $886.90M |
| PP&E, net | $4.10B | $3.64B |
| Goodwill | $1.32B | $1.28B |
| Intangibles | $308.30M | $297.80M |
| Total assets | $7.09B | $6.53B |
| Current liabilities | $836.40M | $841.00M |
| Short-term debt | $43.60M | $138.60M |
| Long-term debt | $2.45B | $2.36B |
| Total debt | $2.49B | $2.50B |
| Total liabilities | $3.81B | $3.69B |
| Shareholders' equity | $2.44B | $2.07B |
| Net debt | $2.42B | $2.41B |
| Cash flow statement | ||
| Operating cash flow | $1.18B | $1.00B |
| Capital expenditure | $736.40M | $642.50M |
| Free cash flow | $439.20M | $360.30M |
| Investing cash flow | -$764.60M | -$653.30M |
| Financing cash flow | -$431.20M | -$330.60M |
| Depreciation & amortization | $327.90M | $299.60M |
| Stock-based compensation | $56.50M | $48.30M |
| Dividends paid | $71.10M | $62.80M |
| Share buybacks | $158.00M | $31.10M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.